Life Sciences & Pharma
Domain-Led AI for the Decisions Between Scientific Evidence and Market Success.
Evalueserve combines life sciences expertise, Data and AI, and managed execution to improve the evidence, intelligence, and commercial workflows that shape portfolio decisions, market access, launch readiness, and long-term growth.
Our Point of View
The Constraint on Life Sciences Innovation Is the Ability to Turn Fragmented Evidence Into Defensible Decisions.
Scientific, clinical, regulatory, market, payer, competitive, and commercial evidence rarely moves through the enterprise as one connected system.
AI can process more of it, but without therapy-area context, evidence logic, traceability, and expert judgment, speed only increases the risk of getting the answer wrong.
The opportunity is to engineer domain knowledge into the workflow itself.
Our Capabilities
Focused Expertise Across the Decisions That Shape Market Success.
Evidence, HEOR & Market Access
Help teams discover, structure, assess, and reuse evidence for systematic literature reviews, value narratives, HTA submissions, payer questions, and market-specific access requirements.
Portfolio, Licensing & Commercial Strategy
Support indication prioritization, opportunity evaluation, epidemiology and forecasting, market sizing, licensing decisions, launch planning, and commercial performance.
Competitive & Market Intelligence
Create always-on intelligence across pipelines, clinical developments, competitors, conferences, markets, regulatory events, and strategic threats.
Scientific, IP & Innovation Intelligence
Improve literature, patent, technology, toxicology, R&D, and innovation workflows through expert research, reusable knowledge structures, and AI-enabled analysis.
Data, Analytics & Knowledge Foundations
Connect fragmented scientific, commercial, and enterprise data; create governed knowledge assets; and build analytics and AI systems that place relevant context into the decision workflow.
Signature Workflows
Complex Life Sciences Workflows We Help Reengineer.
Connect evidence discovery, screening, extraction, synthesis, risk analysis, payer-question preparation, and submission support—with expert checkpoints and source-level traceability.
Use specialized agents and domain review to increase review capacity, reduce repetitive manual effort, and maintain an evidence base as new studies emerge.
Bring together epidemiology, unmet need, competitive activity, market access, pricing, and commercial assumptions to evaluate indications, assets, partnerships, and licensing opportunities faster.
Turn clinical, scientific, regulatory, company, and event signals into curated intelligence that supports portfolio, medical, and commercial decisions.
Combine epidemiology, patient flows, market events, access assumptions, and brand performance to strengthen long-range forecasts and commercial planning.
Accelerate technical research while maintaining the domain review, traceability, and contextual judgment required for defensible R&D and IP decisions.
Client Impact
Proven Results at Scale.
Evidence that better workflows produce better outcomes.
- Swipe to See More
Insights
A Deeper View of Life Sciences & Pharma Performance and Value Realization.
The Quiet Narrowing: The AI Risk Nobody Has An Alert For
AI systems are becoming increasingly effective, but they may also be narrowing the range of signals they detect. Discover why preserving domain expertise and data diversity is essential for trustworthy AI in pharma.
Using AI-Led Analysis to Help Donors and Governments Navigate the Great Funding Realignment
Discover the implications of AI-led analysis on the future of global health financing and its effects on Africa’s health gains.
The ROI of Gen AI
A practical roadmap to value creation. Learn how leading enterprises are turning Generative AI into measurable revenue growth and ROI.
Navigating the Nexus of Innovation and Healthcare in APAC
With AI, big data, and regulatory advancements at the forefront, the sector is poised to deliver innovations that address healthcare challenges while ensuring equitable access across the region’s diverse markets.
- Swipe to See More
Life Sciences Expertise
Meet Our Domain Experts.
Meet the life sciences specialists who combine scientific, commercial, and market access expertise with Data and AI to improve high-value workflows.
- Swipe to See More
Frequently Asked Questions
Life Sciences & Pharma Capabilities.
Evalueserve applies specialized agents, evidence structures, and expert review to support evidence discovery, screening, extraction, synthesis, risk analysis, payer-question preparation, and submission readiness.
Life sciences specialists define the evidence logic, validate critical outputs, manage exceptions, and maintain source-level traceability. This allows AI to increase speed and capacity without removing the expert oversight required for high-stakes market access decisions.
Yes. Evalueserve can build, manage, curate, validate, and continuously improve recurring research, evidence, competitive intelligence, analytics, and knowledge workflows.
Engagements can include dedicated domain teams, platform administration, quality control, ongoing monitoring, expert validation, and continuous workflow improvement.
Domain specialists are involved throughout the workflow rather than reviewing the output only at the end.
They help define decision rules, evidence standards, thresholds, edge cases, and escalation requirements. They also validate critical outputs and maintain source-level traceability so that AI-supported work remains defensible and appropriate for scientific, regulatory, access, and commercial decisions.
Evalueserve supports several engagement models:
- Research, analytics, or advisory projects
- Data and AI solution design and implementation
- Workflow transformation
- Dedicated domain teams
- AI-enabled managed services
- Combined build-and-operate engagements
The right model depends on the workflow, existing data and technology environment, level of internal expertise, and the degree of ongoing execution required.